CFTR corrector 2

• UNSPSC Description:

  CFTR corrector 2 is a cystic fibrosis transmembrane conductance corrector (CFTR), extracted from patent US20140274933[1].

• Target Antigen:

  Autophagy; CFTR

• Type:

  Reference compound

• Related Pathways:

  Autophagy;Membrane Transporter/Ion Channel

• Field of Research:

  Inflammation/Immunology; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cftr-corrector-2.html

• Purity:

  98.92

• Solubility:

  DMSO : 62.5 mg/mL (ultrasonic)

• Smiles:

  O=C(N(C)C1=CC=C2N=C(C)OC2=C1)CN(N=C(C3=CC=CC(F)=C3)C4=C5C=C(OCC)C=C4)C5=O

• Molecular Weight:

  486.49

• References & Citations:

  [1]Bridget M. Cole, et al. PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS. US20140274933.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  Phase 2

• CAS Number:

  1628416-28-3